A Study to Assess the Safety of Subcutaneous Secukinumab for Treatment in Adult Indian Participants With Axial Spondyloarthritis (axSpA), Ankylosing Spondylitis (AS), and Non-Radiographic Axial Spondyloarthritis (nr-axSpA)

NCT07737730 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Axial Spondyloarthritis
Ankylosing Spondylitis
Non-Radiographic Axial Spondyloarthritis

Sponsor

Novartis Pharmaceuticals